Thursday, January 21, 2021
News

Russian envoy says cooperation in countering COVID-19 priority area of bilateral partnership

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | December 2, 2020 1:12:40 AM IST
After phase 2/3 clinical trials for Sputnik V commenced in India on Tuesday, Russian Ambassador Nikolay Kudashev said comprehensive cooperation in countering the spread of coronavirus is a priority area of the Russia-India bilateral and multilateral strategic partnership.

"Comprehensive cooperation in countering the spread of novel coronavirus infection is a priority area of the Russia India bilateral and multilateral strategic partnership. Ready to continue every interaction and coordination in this area to support global efforts to combat COVID-19," Nikolay Kudashev tweeted.

Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories on Tuesday said they have commenced adaptive Phase 2/3 clinical trials for the vaccine.

Russia became the first country to register the world's first Covid-19 vaccine on August 11. Sputnik V was developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry.

The Sputnik V vaccine is based on a well-studied human adenoviral vector platform that had proven safe and effective with no long-term side effects in more than 250 clinical trials globally conducted during the past two decades (while the history of use of human adenoviruses in vaccine development started in 1953). More than 100,000 people have received approved and registered drugs based on the human adenoviral vectors.

Last month, Russia said that its vaccine Sputnik V is 92 per cent effective at protecting people from COVID-19 according to the first interim analysis.

"The Sputnik V vaccine efficacy amounted to 92 per cent (calculation based on the 20 confirmed Covid-19 cases split between vaccinated individuals and those who received the placebo)," the RDIF said in a statement read.

Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik in October.

DCGI has granted permission to pharmaceutical giant Dr Reddy's Laboratories for conducting tests. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE WORLD NEWS
Biden appoints Dan Smith as acting secre...
Biden planning to return US to Paris cli...
Incredible four years, says Trump before...
Trump pardons former Google engineer Ant...
Trump leaves Biden a note in White House...
Kamala Devi Harris sworn in as Vice Pres...
More...
 
INDIA WORLD ASIA
Mamata is contesting from Nandigram as s...
COVID-19 tests cross 1 cr-mark in Delhi,...
Four arrested in Telangana for trafficki...
Former Arunachal Governor Mata Prasad pa...
Anti-cow slaughter ordinance 'constituti...
Kochi receives 23 boxes of Covishield va...
More...    
 
 Top Stories
73.2% unaware where Tibetan Govt in... 
Karnataka to promote Bengaluru Rose... 
Rahul scores in injury time as Kera... 
In historic rite, Biden, Harris swo... 
VP Harris swears in 3 new senators,... 
COVID-19 tests cross 1 cr-mark in D... 
Nearly 80% believe India's actions ... 
WhatsApp investment tips' land two ...